Mostrar el registro sencillo del ítem
TUBERCULOSIS ENFERMEDAD REEMERGENTE. MULTIRRESISTENTE. REPORTE DE UN CASO
dc.contributor.author | Saturno, Darío | |
dc.contributor.author | Eblen, Antonio | |
dc.date.accessioned | 2019-10-16T14:09:16Z | |
dc.date.available | 2019-10-16T14:09:16Z | |
dc.date.issued | 2019-05 | |
dc.identifier.govdoc | CA2019000125 | |
dc.identifier.govdoc | pp 200202AR1401 | |
dc.identifier.issn | 2665-024X | |
dc.identifier.other | 1690-3293 | |
dc.identifier.uri | http://bdigital2.ula.ve:8080/xmlui/654321/2880 | |
dc.description.abstract | La tuberculosis enfermedad infecciosa prevenible y curable, causada por Mycobacterium tuberculosis cuyo tratamiento es por cuatro fármacos (Isoniazida, Rifampicina, Pirazinamida y Ethambutol), que se administran por seis meses. La Organización Mundial de la Salud refiere para Venezuela en el año 2016 8542 casos de tuberculosis, con un 86% pulmonar y con un estimado de multirresistencia de 2.9% en casos nuevos y de 13% en ya tratados anteriormente. Se reporta un caso de una paciente femenina ya tratada (abandono de tratamiento) quien presento cuadro clínico compatible con tuberculosis pulmonar, se realiza los estudios (cultivo) resultando con resistencia a medicamentos empleados en primera línea (Isoniazida y Rifampicina), por lo que se inicia tratamiento con: Cicloserina, Etionamida, Pirazinamida, Levofloxacina y linezolid, que debería cumplir 16 meses. | en_US |
dc.description.abstract | Tuberculosis is a preventable and curable infectious disease caused by Mycobacterium tuberculosis and its treatment is by four drugs (Isoniazide, Rifampicin, Pyrazinamide and Ethambutol), which are administered for six months. The World Health Organization refers to Venezuela, 8542 cases of tuberculosis in the year 2016, with 86% pulmonary and a multiresistance estimate of 2.9% in new cases and 13% in previously treated cases. We report a case of female patient already treated (abandonment of treatment) who presented a clinical picture compatible with pulmonary tuberculosis studies were carried out (culture) resulting with resistance to medicines used in the first line (Isoniazide and Rifampicin), that treatment what started with: Cycloserine, Ethionamide, Pyrazinamide, Levofloxacin and Linezolid; that should be completed for 16 months. | en_US |
dc.language.iso | es | en_US |
dc.publisher | Universidad de Carabobo | en_US |
dc.subject | tuberculosis | en_US |
dc.subject | tratamiento | en_US |
dc.subject | multirresistencia | en_US |
dc.subject | tuberculosis | en_US |
dc.subject | treatment | en_US |
dc.subject | multidrug resistant | en_US |
dc.title | TUBERCULOSIS ENFERMEDAD REEMERGENTE. MULTIRRESISTENTE. REPORTE DE UN CASO | en_US |
dc.title.alternative | TUBERCULOSIS REEMERGING DISEASES. MULTIDRUG RESISTANT. A REPORT CASE. | en_US |
dc.type | Article | en_US |